Back to Search
GEORGE BOSL, MD
MD
Medical Oncology Physician
NPI: 1679544605Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
120723(NY)
Research & Publications (20)
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
PMID 19547919·Invest New Drugs·2010
3-trial
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
PMID 19396148·Mod Pathol·2009
8-other
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
PMID 18410903·Biol Blood Marrow Transplant·2008
8-other
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
PMID 18172902·Cancer·2008
8-other
Treatment of stage I seminoma: is it time to change your practice?
PMID 18992162·J Hematol Oncol·2008
8-other
In vivo differentiation and genomic evolution in adult male germ cell tumors.
PMID 17943972·Genes Chromosomes Cancer·2008
4-observational
Clinical outcome and predictors of survival in late relapse of germ cell tumor.
PMID 18936477·J Clin Oncol·2008
8-other
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
PMID 17437432·BJU Int·2007
8-other
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
PMID 17520176·Invest New Drugs·2007
3-trial
Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials.
PMID 17637730·Nat Clin Pract Oncol·2007
8-other
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
PMID 17906201·J Clin Oncol·2007
8-other
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
PMID 17998544·J Clin Oncol·2007
8-other
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
PMID 17296380·J Urol·2007
8-other
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
PMID 17194908·J Clin Oncol·2007
3-trial
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
PMID 17235042·J Clin Oncol·2007
3-trial
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
PMID 17261854·J Clin Oncol·2007
8-other
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
PMID 17177200·Cancer·2007
8-other
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
PMID 18065732·J Clin Oncol·2007
4-observational
Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
PMID 17138961·Stem Cells·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1679544605
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile